NCT04149431 is a Phase 3 clinical trial of Derinat in Respiratory Infections in Children, sponsored by PharmPak, LLC.

Who is sponsoring NCT04149431?

NCT04149431 is sponsored by PharmPak, LLC.

What drugs are being tested in NCT04149431?

Interventions in NCT04149431: Derinat.

What condition does NCT04149431 study?

NCT04149431 studies Respiratory Infections in Children.

Is NCT04149431 still recruiting?

NCT04149431 is currently status unknown. Last updated 4 November 2019.

Last reviewed 2019-11-04 · How we verify

NCT04149431

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Multicenter Study to Evaluate Efficacy, Tolerability, Safety of Derinat

Status unknown Phase 3 Last updated 4 November 2019

What this trial tests

Phase 3 trial testing Derinat in Respiratory Infections in Children in 350 participants. Status unknown.

Timeline

15 December 2019

Primary endpoint
31 May 2022

31 May 2022

Quick facts

Lead sponsor	PharmPak, LLC
Phase	Phase 3
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	treatment
Enrollment	350
Start date	15 December 2019
Primary completion	31 May 2022
Estimated completion	31 May 2022
Sites	1 location across Russia

Drugs / interventions tested

Derinat — full drug profile →

Conditions studied

Respiratory Infections in Children — all drugs for Respiratory Infections in Children →

Sponsor

PharmPak, LLC — full company profile →

Who can join

Adults 1 Day to 18, any sex, with Respiratory Infections in Children. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This multicenter prospective double blinded placebo-controlled randomized study is designed to to evaluate clinical efficacy, tolerability and safety of medical product Derinat®, solution for external and local use 0.25% in acute infections of respiratory system in children

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04149431 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by PharmPak, LLC
Last refreshed: 4 November 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04149431.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing